CD24 functions as an immune checkpoint in ovarian cancer (Gu et al., 2023), where cells evade phagocytosis by macrophages through the interaction of CD24 molecules with the inhibitory receptor sialic acid-binding immunoglobulin-like lectin 10 (Siglec-10) on tumor-associated macrophages. Here, CD24 is linked to ovarian carcinoma.